Universal Health Services, Inc.
UHS Healthcare Medical Care Facilities
Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024. In the quarter to June 2026, revenue grew 8.27%, EPS grew 9.47%, free cash flow fell 23.8% and total debt rose 5.87%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
Follow UHS
Universal Health Services, Inc. (UHS) Return on equity
Universal Health Services, Inc.'s return on equity over the twelve months to 30 June 2026 was 20.8%, down 0.3 percentage points from fiscal 2025 (21.1%). Over the past ten years it has ranged from 11.1% (fiscal 2022) to 21.1% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Care Facilities industry median of 8.76% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 21.1% | 3.50 |
| FY2024 | 17.6% | 5.84 |
| FY2023 | 11.8% | 0.70 |
| FY2022 | 11.1% | (4.65) |
| FY2021 | 15.8% | 0.04 |
| FY2020 | 15.7% | 0.99 |
| FY2019 | 14.7% | (0.09) |
| FY2018 | 14.8% | (0.78) |
| FY2017 | 15.6% | (0.18) |
| FY2016 | 15.8% | (1.03) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| CON Concentra Group Holdings Parent, Inc. compare | 47.7% |
| THC Tenet Healthcare Corporation compare | 37.3% |
| PACS PACS Group, Inc. compare | 27.9% |
| CHE Chemed Corporation compare | 27.1% |
| UHS Universal Health Services, Inc. | 20.8% |
| EHC Encompass Health Corporation compare | 19.3% |
| ENSG The Ensign Group, Inc. compare | 17.0% |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 6.77% |
| DVA DaVita Inc. compare | −287.3% |
| Medical Care Facilities industry median | 8.76% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on UHS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement